TeraRecon provides advanced visualization and artificial intelligence solutions for medical imaging.

TeraRecon

TeraRecon, Inc. | 10,627 followers on LinkedIn. A ConcertAI company that is a solution provider for AI-empowered radiology, oncology, cardiology, neurology, and more. | Serving ~1,900 clinical sites globally, TeraRecon, a ConcertAI company, is a Best in KLAS solution provider for AI-empowered radiology, oncology, cardiology, neurology, and vascular surgery. Awarded the KLAS Category Leader for Advanced Visualization, TeraRecon solutions are independent of any one manufacturer&#39;s imaging equipment or PACS system, allowing a single, unified, and simplified clinical workflow that can improve efficiencies and deliver actionable physician-guided insights.

Jan Hardenbergh

Kevin Sean Lev

Director, Solution Support at TeraRecon, Inc.

Srinivasan Sukumar

Chikako Goodman

TeraRecon, Inc.

Detecting and proactively addressing heart-related conditions involving the mitral valve and left atrial appendage can be challenging, particularly when it comes to reducing stroke risks in atrial fibrillation patients or treating diseases in the early stages. Read our white paper to dig deeper into some of the challenges faced in the diagnosis and treatment of structural heart diseases, including the repair and replacement of damaged heart valves or/and reducing the risk of thrombus formation in the heart. Download the white paper now: https://hubs.ly/Q02qZnTp0 #structuralheart #whitepaper #medicalimaging

Intuition 4.10, TeraRecon's latest advanced visualization software, is our most significant update in years. With AI productivity, novel cardiac MR medical imaging workflows, and over 200 other enhancements, Intuition 4.10 delivers even greater precision for cardiac CT and MR. Plus, it's now available on a robust, cloud-based SaaS platform – part of our entire portfolio of cloud-enabled solutions. We can't wait to show you all that 4.10 has to offer! If you're planning to be at RSNA Annual Meeting in Chicago (Dec. 1-5), we'd love to give you a tour and demonstrate the breadth and depth of our end-to-end, AI-enabled advanced visualization clinical workflows. Schedule a meeting with TeraRecon at RSNA 2024: https://hubs.ly/Q02Xc-PJ0 #AdvancedVisualization #TeraRecon #CardiacMR #CardiacCT #RSNA

When undertreatment can lead to disease recurrence and overtreatment to unnecessary complications in liver or kidney ablation therapy, you need a careful planning tool. Did you know that TeraRecon's segmentation workflows can guide ablation therapy and help you carefully plan your procedures to maximize treatment success? If you're planning to be at RSNA Annual Meeting in Chicago (Dec. 1-5), let us show you the breadth and depth of our end-to-end advanced imaging workflows. Schedule a meeting with TeraRecon at RSNA 2024: https://hubs.ly/Q02WD1Wg0 #AdvancedVisualization #TeraRecon #TreatmentPlanning #RSNA

TeraRecon is excited to announce the release of Intuition 4.10, our latest version of the best-in-class advanced visualization software packed with AI productivity and novel cardiac MR medical imaging workflows. With over 200 enhancements, the new Intuition 4.10 delivers unmatched precision for cardiac CT and MR, and is now available on a robust, cloud-based SaaS platform. "This release allows me to start standardizing my post-processing cardiac workflows onto a single, broad tool for imaging workflows," says Dr. Christopher Maroules MD, COO of Innovation Health Services. "The versatility of the dedicated cardiac MR viewer and various cardiac MR workflows enable me to conduct my day-to-day cardiac MR analysis in a streamlined and consistent manner." Find out more: https://hubs.ly/Q02Vx_f20 #Intuition #AdvancedVisualization #CardiacMR #medicalimaging #AI #SaaS

🎗️ October is Breast Cancer Awareness Month! Let's come together this month to raise awareness, support those affected, and celebrate the incredible progress in breast cancer detection and treatment. We are proud to join forces with ClariPi Inc. by integrating their innovative solution, ClariSIGMAM, into the Eureka Clinical AI platform. ClariSIGMAM aims to dramatically improve the identification of breast tissue abnormalities. Schedule a meeting to learn more about ClariPi’s solutions available on the Eureka Clinical AI platform: https://hubs.ly/Q02TXrl70 #pinktober #BreastCancerAwarenessMonth #breastdensity #ClariPi #TeraRecon

RSNA 2024 will be here before you know it -- will we see you there? Come explore our latest updates and find out why TeraRecon is an award-winning solution provider for AI-empowered radiology, oncology, cardiology, neurology, and vascular surgery. Let us show you how Intuition and Eureka can deliver clinical decision support across your enterprise. Schedule a meeting in advance: https://hubs.ly/Q02PTr8W0 #RSNA24 #healthcareinnovation #AI #EurekaClinicalAI #Intuition #TeraRecon

September is World Alzheimer's Month, an international campaign to raise awareness and to challenge the stigma that persists around Alzheimer’s disease and all types of dementia. With that in mind, we’re spotlighting Combinostics' cMRI solution which is available via TeraRecon’s Eureka Clinical AI platform. Combinostics’ cMRI software is CE-marked and FDA-approved. It provides fully automated brain MRI quantification with focus on dementia. The software assists with objective detection and differentiation of Alzheimer’s disease from other dementia forms. Using T1 and FLAIR sequences, a patient’s individual brain morphometry pattern, white matter hyperintensities, and disease-specific imaging biomarkers are quantified and compared to a large reference database of healthy controls. Learn more about Combinostics' cMRI solution: https://hubs.ly/Q02Qxfvh0 Learn more about the AI solutions available on Eureka Clinical AI: https://hubs.ly/Q02QxwXF0 #WorldAlzheimersMonth #TeraRecon #Eureka #Alzheimers #Combinostics #MRI #MRIquantification

Day one of #BSCI2024 has been a blast! We're very excited to be here and can't wait to keep the conversations going tomorrow. Come by our booth to see our latest #cardiology solutions in action. #BSCCT2024 #radiology #medicalimagining #healthcareinnovation #TeraRecon #ConcertAI https://hubs.ly/Q02QtKHP0

We are excited to be exhibiting at BSCI 2024 in Sheffield, UK this week! Visit us to see our gold-standard Intuition cardiac solutions in action and explore AI cardiac capabilities available on the Eureka Clinical AI platform. #BSCI2024 #BSCCT2024 #cardiology #radiology #TeraRecon #ConcertAI https://hubs.ly/Q02PZqts0

TeraRecon Sales Sidekick

Eureka Clinical AI

Aquarius Mobile

Domain Not Resolving

Amazon

DNSSEC

LetsEncrypt

Mobile Non Scaleable Content

IPv6

Apple Mobile Web App Capable

Amazon Virginia Region

ASP.NET

President

Dan McSweeney

Chief Financial Officer

Martin Clancy

CTO & VP Engineering

T.C. Zhao

Global CxO/COO SaaS Leader | Board Member | Hyper Growth Accelerator

Tina Hsiao

VP of Human Resources

Ana Bilbao

SVP, Sales & Services

Chris Massoll

Vice President of Client Services and Japan Operations

Darrell Trump

Vice President Sales

Kurt Farhy

Vice President of Strategic Alliances

Margie Lawlor

Raja N. Ghanem

VP of Product Marketing

Jeffrey Sorenson

Founder & Board Member

Romesh Wadhwani

Interim CEO

Pradyut Shah

Director

United States Manufacturing Companies (Top 10K)

Manufacturing Acquired Companies (Top 10K)

West Coast Companies that Exited (Top 10K)

West Coast Acquired Companies With More Than $50M in Revenue

TeraRecon is the largest independent provider and a global leader in advanced image processing innovation for CT, MR and PET, advanced imaging-based decision support and 3D visualization techniques. A 7-time winner of Frost and Sullivan awards, the company has developed a leading portfolio of products and technologies that advance the performance, quality, functionality, and integration of image processing and 3D visualization systems since its founding in 1997. In 2010, TeraRecon was awarded the “Company of the Year” award for European Advanced Visualization Applications, and the “North American Growth Leadership of the Year Award” for Advanced Visualization and Clinical Applications, both by respected independent market research firm Frost and Sullivan. 


TeraRecon is a privately held company with headquarters in Foster City, California, USA, European headquarters in Frankfurt, Germany, and branch offices in Concord, Massachusetts, USA and Tokyo, Japan.

Venture Round - Terarecon

Computer and Software Services and Scientific Services

Foster City

California

United States

North America

Terarecon

TeraRecon’s New Intuition Product Line Delivers AI Productivity and Industry-leading Cardiac MR Workflows, All Delivered Through a Robust Software-as-a-Service (SaaS) Platform

ConcertAI's TeraRecon Launches Three New Care Suites, Life Sciences Platform, and Strategic Partnerships at #ECR24

Terarecon Applauded By Frost & Sullivan For Solving Time-Related Challenges In Neurological Care And Its Market ...

Advanced (3D/4D) Visualization Systems Market Set for Explosive Growth| Visualization Sciences, TeraRecon, Vis

ConcertAI's TeraRecon Enhances its Eureka Clinical AI ...

ConcertAI's TeraRecon Enhances its Eureka Clinical AI Platform with AI-Based Prostate Cancer Diagnostic Solutions from Lucida Medical

Hyperscale Data Center Capacity to Almost Triple in Next Six ...

FEops Partners with TeraRecon to Scale the ...

ConcertAI's TeraRecon Expands its Clinical AI Offering in Cardiac Care with FEops' HEARTguide Digital Twin Solution

ConcertAI's TeraRecon Partners with ImageBiopsy Lab to Bring Cutting-Edge Musculoskeletal solutions to the Eureka Clinical AI Platform

news impact assignment basic	general
public peers	general	Nov 6, 2024 11:11 PM	95401ea4
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 6, 2024 11:11 PM	b29ec347
crunchbase trigger	general	Nov 6, 2024 11:11 PM	958486cd
crunchbase profile	general	Nov 7, 2024 7:49 PM	f48a780d
li profile	general	Nov 6, 2024 11:11 PM	b34e01e8
translate crunchbase fundingrounds	general	Nov 7, 2024 8:31 PM	54439ff1
peers	general	Nov 6, 2024 11:11 PM	631e9936
news basic	general	Nov 6, 2024 11:11 PM	96978bc4
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

TERA

COM:TERARECON

TeraRecon